AKT1/3 (pTyr434), (pTyr437) anticorps
-
- Antigène
- AKT1/3
-
Épitope
- pTyr434, pTyr437
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Inconjugué
-
Application
- ELISA, Western Blotting (WB), Immunohistochemistry (IHC)
- Réactivité croisée
- Humain, Souris, Rat
- Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogène
- Synthesized peptide derived from Human Akt1/3 around the phosphorylation site of Y437/434.
- Isotype
- IgG
-
-
- Indications d'application
- WB:1:500-1:2000, IHC:1:100-1:300, ELISA:1:20000,
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- AKT1/3
- Autre désignation
- AKT1/AKT3
- Sujet
- AKT1, PKB, RAC, RAC-alpha serine/threonine-protein kinase, Protein kinase B, PKB, Protein kinase B alpha, PKB alpha, Proto-oncogene c-Akt, RAC-PK-alpha, AKT3, PKBG, RAC-gamma serine/threonine-protein kinase, Protein kinase Akt-3, Protein ki
- UniProt
- P31749, Q9Y243
-